Could Your Medication Be Causing That Ringing?
Realising that a medication you depend on might be responsible for a new ringing or buzzing in your ears can feel unsettling. You’re not imagining it, and you’re not alone in making that connection. Drug-induced tinnitus is one of the few forms of tinnitus with a clearly identifiable cause, and that is genuinely useful information. Knowing which drug class is involved tells you a great deal about whether the tinnitus is likely to resolve, and what your next step should be. This article walks through the major drug classes, what reversibility actually means for each, and a clear action plan.
Which Medications Can Cause Tinnitus?
Over 200 medications are classified as ototoxic, but the most important distinction for patients is reversibility: tinnitus from high-dose aspirin or NSAIDs typically resolves when the drug is stopped, while damage from aminoglycoside antibiotics and cisplatin chemotherapy is often permanent, making new tinnitus during these treatments an urgent reason to contact your prescriber (Seligmann et al. (1996)).
The major drug classes linked to tinnitus include:
- High-dose aspirin and salicylates — the most commonly encountered reversible cause
- NSAIDs (ibuprofen, naproxen, diclofenac) — reversible at high or prolonged doses
- Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin, neomycin) — risk of permanent damage
- Platinum-based chemotherapy (cisplatin, carboplatin) — high risk of permanent damage
- Loop diuretics (furosemide, ethacrynic acid) — variable; route and dose matter significantly
- Antimalarials (quinine, chloroquine) — typically reversible
- Macrolide antibiotics (azithromycin, erythromycin, clarithromycin) — elevated risk confirmed by recent large-scale evidence
- Certain cardiac and psychotropic drugs — less common; class-dependent reversibility
The word “ototoxic” simply means toxic to the inner ear. Tinnitus is often the earliest sign — it can appear before any measurable change in your hearing shows up on a standard test (Seligmann et al. (1996)).
The Reversibility Divide: Temporary vs. Permanent Risk
Understanding reversibility comes down to one biological fact: human cochlear hair cells do not regenerate. When a drug kills them, that damage is permanent. When a drug temporarily disrupts their function without killing them, the effect can reverse once the drug is cleared.
Typically reversible
High-dose aspirin and salicylates work by inhibiting prostaglandin synthesis in the cochlea, which disrupts the function of prestin — a motor protein in outer hair cells. The cells are not destroyed; they are temporarily altered. Aspirin-induced tinnitus generally requires doses of around 2,000 mg per day or more before cochlear effects appear (Federspil (1990)). Reduce the dose or stop the drug, and the tinnitus typically clears. Standard low-dose aspirin (75–100 mg) used for cardiovascular prevention does not carry this risk: a large cohort study of 69,455 women found that low-dose aspirin use was not associated with increased tinnitus risk (Curhan et al., as cited in the research evidence base).
NSAIDs at high or sustained doses carry a similar, dose-dependent mechanism. The risk is most relevant for people taking NSAIDs regularly at high doses for chronic pain, not those taking occasional standard doses for a headache.
Quinine and antimalarials cause tinnitus through a mechanism that also disrupts outer hair cell function without permanent destruction in most cases. Tinnitus from these drugs is typically reversible, though no modern controlled trial has confirmed precise reversal rates — hedge your expectations accordingly.
Risk of permanent damage
Aminoglycoside antibiotics are selectively taken up by cochlear outer hair cells, where they generate reactive oxygen species that cause irreversible cell death (Federspil (1990)). Tinnitus rates across studies range from 0–53% depending on dose, duration, and co-exposures (Diepstraten et al. (2021)). The damage does not reverse when the antibiotic is stopped, because the cells are gone.
Cisplatin and carboplatin destroy cochlear hair cells through a combination of direct DNA damage and oxidative stress, beginning at frequencies above 6,000 Hz and progressing toward speech frequencies over time. Published literature reports hearing impairment in up to 80% of treated patients in some series, with the effect continuing or worsening after treatment ends (Janowiak-Majeranowska et al. (2024)). Delayed onset — where hearing worsens months after the last dose — has been documented, with monitoring recommended for up to 10 years post-treatment.
Ethacrynic acid (a loop diuretic) combined with aminoglycosides is a particularly high-risk combination: the two drugs act synergistically, causing more damage together than either would alone.
Tinnitus as an Early Warning Sign: Why You Should Act Fast
Here is something that most articles on this topic leave out, and it matters practically.
Ototoxic damage follows a predictable sequence. It begins at the highest frequencies, typically 8,000 Hz and above, well outside the range of normal conversation. Standard hearing tests — the kind done in most clinics — only measure 250 to 8,000 Hz. This means that by the time a routine audiogram catches a problem, meaningful cochlear damage may already have occurred (Campbell & Le (2018)).
Tinnitus often appears before that threshold is crossed. It is the cochlea signalling distress before the damage has extended into the range a standard test will detect. For patients on aminoglycosides, cisplatin, or high-dose IV loop diuretics, new tinnitus is not a side effect to quietly endure — it is a reason to contact your prescriber the same day.
The American Speech-Language-Hearing Association’s guidelines state clearly: if any symptoms of cochlear toxicity arise during treatment with these drugs, the physician must be notified immediately (ASHA (1994)). Extended high-frequency audiometry, which tests above the standard 8,000 Hz ceiling, can detect early damage in time for a clinical response.
This is not meant to cause alarm. The point is the opposite: catching a signal early gives you and your clinical team options. Waiting to see whether things improve on their own is the approach most likely to result in avoidable, permanent damage.
If you develop new tinnitus while taking cisplatin, aminoglycoside antibiotics, or high-dose intravenous diuretics, contact your prescriber promptly — do not wait for a routine appointment.
What Increases Your Risk? Factors That Amplify Ototoxicity
Not everyone exposed to an ototoxic medication develops tinnitus or hearing loss. Several factors increase the probability of cochlear damage:
- Kidney impairment. Many ototoxic drugs are cleared by the kidneys. When kidney function is reduced, drug levels in the blood accumulate higher and remain elevated longer, increasing cochlear exposure. This applies particularly to aminoglycosides and loop diuretics (Seligmann et al. (1996)).
- Combining ototoxic drugs. Taking an aminoglycoside antibiotic alongside a loop diuretic is the classic high-risk combination — the two drugs interact synergistically, and the resulting cochlear damage is greater than either drug alone would produce (Federspil (1990)).
- Dose and duration. Higher doses and longer courses of treatment consistently increase ototoxic risk across all classes. This is one reason regular audiological monitoring is recommended for patients on extended courses of cisplatin or aminoglycosides.
- Intravenous bolus delivery. With loop diuretics, how the drug is delivered matters. A rapid intravenous bolus carries meaningfully higher ototoxic risk than slow IV infusion or oral dosing, because peak drug concentrations in cochlear fluid are much higher (Federspil (1990)).
- Genetic susceptibility. Some people carry a variant in the MT-RNR1 mitochondrial gene that dramatically increases sensitivity to aminoglycoside antibiotics. If you or a family member has had severe hearing loss after a short course of antibiotics, this is worth raising with your doctor before any future aminoglycoside treatment (May et al. (2023)).
The combination of kidney impairment, an aminoglycoside antibiotic, and a loop diuretic carries the highest known ototoxic risk. If you are in this situation, ask your prescriber whether all three are necessary simultaneously.
What Should You Do If You Think Your Medication Is Causing Tinnitus?
The most important rule first: do not stop a prescribed medication without speaking to your prescriber. The American Tinnitus Association puts it directly — the risk of stopping a medication may far exceed any potential benefit from reducing the tinnitus. This is especially true for antibiotics treating active infection, chemotherapy, or medications managing a serious cardiovascular or neurological condition.
Here is a practical sequence:
Step 1: Note the timeline. Write down when the tinnitus started, whether it appeared shortly after beginning the medication or after a dose increase, and whether it is constant, intermittent, or changing. This information will help your prescriber assess the likelihood of a drug link.
Step 2: Contact your prescriber promptly. Do not wait for a routine follow-up if the tinnitus started during a course of aminoglycosides, cisplatin, or high-dose IV diuretics. For OTC medications (ibuprofen, aspirin), a call to your GP is appropriate rather than emergency contact.
Step 3: Ask about audiological monitoring. If you are on a cisplatin or aminoglycoside course, ask your prescriber whether baseline extended high-frequency audiometry was arranged. ASHA guidelines recommend this be done before or within 72 hours of the first aminoglycoside dose, and no later than 24 hours after the first cisplatin dose (ASHA (1994)). If monitoring was not arranged, ask now.
Step 4: Ask about alternatives. If the ototoxic drug is being used for a non-urgent or non-critical indication, ask your prescriber whether a lower-risk alternative exists. This is a reasonable question and a good prescriber will not be offended by it.
A note on OTC medications: ibuprofen and aspirin taken at standard doses for occasional pain rarely cause tinnitus. The risk emerges with long-term moderate-to-high dose use. If you take NSAIDs or aspirin regularly, this is worth mentioning to your GP at your next appointment.
If you develop tinnitus while taking a prescribed medication, your instinct may be to stop the drug immediately. Resist that impulse. Contact your prescriber first — they can assess whether the drug is the cause and whether a safer alternative exists.
Key Takeaways: What Matters Most
Three things worth remembering from everything above:
First, many medications linked to tinnitus — particularly OTC painkillers like ibuprofen and aspirin at non-prescription doses — cause tinnitus that is reversible when the dose is reduced or stopped. The risk at standard doses is low.
Second, tinnitus during a course of aminoglycoside antibiotics, cisplatin, or high-dose intravenous diuretics is an early warning that warrants same-day contact with your prescriber. These drugs can cause permanent cochlear damage, and tinnitus often appears before that damage becomes detectable on a standard hearing test.
Third, never stop a prescribed medication on your own. Always involve your prescribing doctor or specialist.
Drug-induced tinnitus is one of the most actionable forms of tinnitus — because it has an identifiable cause. Knowing which drugs carry risk, understanding what reversibility means in practice, and knowing when to act puts you in a much stronger position than most people who experience tinnitus onset. That knowledge is the point of this article.
